Intravital imaging of mesenchymal stem cell trafficking and association with platelets and neutrophils

Stem Cells

Volumn 33, Issue 1, 2015, Pages 265-277

  Teo, Grace Sock Leng ^a,b,c,d,e   Yang, Zijiang ^a,b,d,e,f   Carman, Christopher V ^b,c   Karp, Jeffrey M ^a,b,d   Lin, Charles P ^b,e,g  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f SHANGHAI JIAO TONG UNIVERSITY   (China)

^g NONE   (United States)

Author keywords

Inflammation; Intravital imaging; Mesenchymal stem cells; Neutrophils; Platelets; Trafficking

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY; CELL ADHESION; CELL HOMING; CELL KINETICS; CELL MIGRATION; CELLULAR DISTRIBUTION; CIRCULATING TUMOR CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXTRAVASCULAR SPACE; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NEUTROPHIL; NONHUMAN; STEM CELL CULTURE; THROMBOCYTE; VENULE; ANIMAL; C57BL MOUSE; CELL MOTION; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PROCEDURES; RADIOGRAPHY;

MURINAE;

ANIMALS; BLOOD PLATELETS; CELL ADHESION; CELL MOVEMENT; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; NEUTROPHILS;

EID: 84919427476     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1848     Document Type: Article

References (71)

1. Porada C, Almeida-Porada G,. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev 2010; 62: 1156-1166.
2. Karp JM, Teo GSL,. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 2009; 4: 206-216.
3. Henschler R, Deak E, Seifried E,. Homing of mesenchymal stem cells. Transfus Med Hemother 2008; 35: 306-312.
4. Chamberlain G, Fox J, Ashton B, et al. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-2749.
5. Song H, Cha M-J, Song B-W, et al. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells 2010; 28: 555-563.
6. Xu J, Wang D, Liu D, et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood 2012; 120: 3142-3151.
7. Levy O, Zhao W, Mortensen L, et al. mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. Blood 2013; 122: e23-32.
8. Sarkar D, Vemula PK, Teo GSL, et al. Chemical Engineering of Mesenchymal Stem Cells to Induce a Cell Rolling Response. Bioconjug Chem 2008; 19: 2105-2109.
9. Sackstein R, Merzaban JS, Cain DW, et al. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 2008; 14: 181-187.
10. Thankamony SP, Sackstein R,. Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells. Proc Natl Acad Sci USA 2011; 108: 2258-2263.
11. Fox J, Chamberlain G, Ashton B, et al. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 2007; 137: 491-502.
12. Spaeth E, Klopp A, Dembinski J, et al. Inflammation and tumor microenvironments: Defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008; 15: 730-738.
13. Ley K, Laudanna C, Cybulsky MI, et al. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7: 678-689.
14. Semon J, Nagy L, Llamas C, et al. Integrin expression and integrin-mediated adhesion in vitro of human multipotent stromal cells (MSCs) to endothelial cells from various blood vessels. Cell Tissue Res 2010; 341: 147-158.
15. Segers VFM, Van Riet I, Andries LJ, et al. Mesenchymal stem cell adhesion to cardiac microvascular endothelium: Activators and mechanisms. Am J Physiol Heart Circ Physiol 2006; 290: H1370-1377.
16. Ruster B, Gottig S, Ludwig RJ, et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006; 108: 3938-3944.
17. Teo G, Ankrum J, Martinelli R, et al. Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms. Stem Cells 2012; 30: 2472-2486.
18. Smith H, Whittal C, Weksler B, et al. Chemokines stimulate bi-directional migration of human mesenchymal stem cells across bone marrow endothelial cells. Stem Cells Dev 2012; 21: 476-486.
19. Langer HF, Stellos K, Steingen C, et al. Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. J Mol Cell Cardiol 2009; 47: 315-325.
20. Labelle M, Hynes R,. The initial hours of metastasis: The importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov 2012; 2: 1091-1099.
21. Sarkar D, Ankrum J, Teo G, et al. Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanisms. Biomaterials 2011; 32: 3053-3061.
22. Mortensen LJ, Levy O, Phillips JP, et al. Quantification of mesenchymal stem cell (MSC) delivery to a target site using in vivo confocal microscopy. PLoS One 2013; 8: e78145.
23. Veilleux I, Spencer JA, Biss DP, et al. In vivo cell tracking with video rate multimodality laser scanning microscopy. IEEE J Sel Top Quant Electron 2008; 14: 10-18.
24. Chen M, Whisler J, Jeon J, et al. Mechanisms of tumor cell extravasation in an in vitro microvascular network platform. Integr Biol 2013; 5: 1262-1271.
25. Granger D, Senchenkova E,. Leukocyte-Endothelial Cell Adhesion. Inflammation and the Microcirculation. San Rafael, CA: Morgan & Claypool Life Sciences, 2010.
26. Fischer U, Harting M, Jimenez F, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev 2009; 18: 683-692.
27. Egawa G, Nakamizo S, Natsuaki Y, et al. Intravital analysis of vascular permeability in mice using two-photon microscopy. Sci Rep 2013; 3: 1932.
28. Majno G, Palade G,. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: An electron microscopic study. J Biophys Biochem Cytol 1961; 11: 571-605.
29. Svensjö E, Arfors K,. Dimensions of postcapillary venules sensitive to bradykinin and histamine-induced leakage of macromolecules. Ups J Med Sci 1979; 84: 47-60.
30. Bienvenu K, Russell J, Granger D,. Leukotriene B4 mediates shear rate-dependent leukocyte adhesion in mesenteric venules. Circ Res 1992; 71: 906-911.
31. Lim L, Solito E, Russo-Marie F, et al. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: Effect of lipocortin 1. Proc Natl Acad Sci USA 1998; 95: 14535-14539.
32. Thiele J, Goerendt K, Stark G, et al. Real-time digital imaging of leukocyte-endothelial interaction in ischemia-reperfusion injury (IRI) of the rat cremaster muscle. J Vis Exp 2012; e3973.
33. Warnock R, Askari S, Butcher E, et al. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med 1998; 187: 205-216.
34. Sadik C, Kim N, Luster A,. Neutrophils cascading their way to inflammation. Trends Immunol 2011; 32: 452-460.
35. Jiang L, Song X, Liu P, et al. Platelet-mediated mesenchymal stem cells homing to the lung reduces monocrotalineinduced rat pulmonary hypertension. Cell Transplant 2012; 21: 1463-1475.
36. Polanowska-Grabowska R, Wallace K, Field JJ, et al. P-Selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. Arterioscler Thromb Vasc Biol 2010; 30: 2392-2399.
37. da Costa Martins P, van den Berk N, Ulfman LH, et al. Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation. Arterioscler Thromb Vasc Biol 2004; 24: 193-199.
38. Brinkmann V, Zychlinsky A,. Neutrophil extracellular traps: Is immunity the second function of chromatin? J Cell Biol 2012; 198: 773-783.
39. Demers M, Wagner D,. Neutrophil extracellular traps: A new link to cancer-associated thrombosis and potential implications for tumor progression. Oncoimmunology 2013; 2: e22946.
40. Cools-Lartigue J, Spicer J, McDonald B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest 2013; 123: 3446-3458.
41. McDonald B, Urrutia R, Yipp B, et al. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 2012; 12: 324-333.
42. Caudrillier A, Kessenbrock K, Gilliss B, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012; 122: 2661-2671.
43. Clark S, Ma A, Tavener S, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13: 463-469.
44. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327: 580-583.
45. Camerer E, Regard J, Cornelissen I, et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest 2009; 119: 1871-1879.
46. Wang L, Dudek S,. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res 2009; 77: 39-45.
47. Bianco P, Robey P, Simmons P,. Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell 2008; 2: 313-319.
48. Bianco P, Cao X, Frenette P, et al. The meaning, the sense and the significance: Translating the science of mesenchymal stem cells into medicine. Nat Med 2013; 19: 35-42.
49. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
50. Chiesa S, Morbelli S, Morando S, et al. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc Natl Acad Sci USA 2011; 108: 17384-17389.
51. Gao Z, Zhang L, Hu J, et al. Mesenchymal stem cells: A potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles. Nanomedicine 2013; 9: 174-184.
52. Studeny M, Marini F, Dembinski J, et al. Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004; 96: 1593-1603.
53. Doyle N, Bhagwan S, Meek B, et al. Neutrophil margination, sequestration, and emigration in the lungs of L-selectin-deficient mice. J Clin Invest 1997; 99: 526-533.
54. Lee RH, Hsu SC, Munoz J, et al. A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Blood 2006; 107: 2153-2161.
55. Wynn RF, Hart CA, Corradi-Perini C, et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004; 104: 2643-2645.
56. Aird W,. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 2007; 100: 174-190.
57. Li X, Ling W, Khan S, et al. Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth. J Bone Miner Res 2012; 27: 1635-1648.
58. Schwarz S, Huss R, Schulz-Siegmund M,. Bone marrow-derived mesenchymal stem cells migrate to healthy and damaged salivary glands following stem cell infusion. Int J Oral Sci 2014; 6: 154-161.
59. Randolph G, Angeli V, Swartz M,. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 2005; 5: 617-628.
60. Johnson LA, Clasper S, Holt AP, et al. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med 2006; 203: 2763-2777.
61. Johnson L, Jackson D,. Cell traffic and the lymphatic endothelium. Ann N Y Acad Sci 2008; 1131: 119-133.
62. Pflicke H, Sixt M,. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J Exp Med 2009; 206: 2925-2935.
63. Nieswandt B, Hafner M, Echtenacher B, et al. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999; 59: 1295-1300.
64. Janowska-Wieczorek A, Majka M, Kijowski J, et al. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 2001; 98: 3143-3149.
65. Ren G, Zhao X, Zhang L, et al. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 2010; 184: 2321-2328.
66. Vestweber D,. Relevance of endothelial junctions in leukocyte extravasation and vascular permeability. Ann N Y Acad Sci 2012; 1257: 184-192.
67. Carman C, Springer T,. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J Cell Biol 2004; 167: 377-388.
68. Schulte D, Küppers V, Dartsch N, et al. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J 2011; 30: 4157-4170.
69. Kim M-H, Curry F-RE, Simon S,. Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous wounding. Am J Physiol Cell Physiol 2009; 296: 56.
70. Sürder D, Manka R, Lo Cicero V, et al. Intracoronary injection of bone marrow derived mononuclear cells, early or late after acute myocardial infarction: Effects on global left ventricular function four months results of the SWISS-AMI trial. Circulation 2013; 127: 1968-1979.
71. Zeuner A, Signore M, Martinetti D, et al. Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor. Cancer Res 2007; 67: 4767-4773.